Graph-Based Biomarker Discovery and Interpretation for Alzheimer's Disease

• URL: http://arxiv.org/abs/2411.18796v1
• Date: Wed, 27 Nov 2024 22:45:19 GMT
• Title: Graph-Based Biomarker Discovery and Interpretation for Alzheimer's Disease
• Authors: Maryam Khalid, Fadeel Sher Khan, John Broussard, Arko Barman,
• Abstract summary: Early diagnosis and discovery of therapeutic drug targets are crucial objectives for the effective management of Alzheimer's Disease (AD) Recent blood tests have shown promise in diagnosing AD and highlighting possible biomarkers that can be used as drug targets for AD management. Here, we introduce BRAIN, a novel machine learning framework to jointly optimize the diagnostic accuracy and biomarker discovery processes.
• Score: 1.859931123372708
• License:
• Abstract: Early diagnosis and discovery of therapeutic drug targets are crucial objectives for the effective management of Alzheimer's Disease (AD). Current approaches for AD diagnosis and treatment planning are based on radiological imaging and largely inaccessible for population-level screening due to prohibitive costs and limited availability. Recently, blood tests have shown promise in diagnosing AD and highlighting possible biomarkers that can be used as drug targets for AD management. Blood tests are significantly more accessible to disadvantaged populations, cost-effective, and minimally invasive. However, biomarker discovery in the context of AD diagnosis is complex as there exist important associations between various biomarkers. Here, we introduce BRAIN (Biomarker Representation, Analysis, and Interpretation Network), a novel machine learning (ML) framework to jointly optimize the diagnostic accuracy and biomarker discovery processes to identify all relevant biomarkers that contribute to AD diagnosis. Using a holistic graph-based representation for biomarkers, we highlight their inter-dependencies and explain why different ML models identify different discriminative biomarkers. We apply BRAIN to a publicly available blood biomarker dataset, revealing three novel biomarker sub-networks whose interactions vary between the control and AD groups, offering a new paradigm for drug discovery and biomarker analysis for AD.

Related papers

• Large Language Models for Bioinformatics [58.892165394487414]
  This survey focuses on the evolution, classification, and distinguishing features of bioinformatics-specific language models (BioLMs) We explore the wide-ranging applications of BioLMs in critical areas such as disease diagnosis, drug discovery, and vaccine development. We identify key challenges and limitations inherent in BioLMs, including data privacy and security concerns, interpretability issues, biases in training data and model outputs, and domain adaptation complexities.
  arXiv  Detail & Related papers  (2025-01-10T01:43:05Z)
• Computational Methods for Breast Cancer Molecular Profiling through Routine Histopathology: A Review [0.2671776059280352]
  Recent advancements in artificial intelligence have enabled digital pathology to analyze histopathologic images for targeted molecular and broader omic biomarkers. These technologies offer the capability to extract various biomarkers such as genomic, transcriptomic, proteomic, and metabolomic markers directly from the routine hematoxylin and eosin stained images.
  arXiv  Detail & Related papers  (2024-12-01T08:13:49Z)
• MMIL: A novel algorithm for disease associated cell type discovery [58.044870442206914]
  Single-cell datasets often lack individual cell labels, making it challenging to identify cells associated with disease. We introduce Mixture Modeling for Multiple Learning Instance (MMIL), an expectation method that enables the training and calibration of cell-level classifiers.
  arXiv  Detail & Related papers  (2024-06-12T15:22:56Z)
• scBeacon: single-cell biomarker extraction via identifying paired cell clusters across biological conditions with contrastive siamese networks [0.9591674293850556]
  scBeacon is a framework built upon a deep contrastive siamese network. scBeacon adeptly identifies matched cell populations across varied conditions. Comprehensive evaluations validate scBeacon's superiority over existing single-cell differential gene analysis tools.
  arXiv  Detail & Related papers  (2023-11-05T08:27:24Z)
• ADMarker: A Multi-Modal Federated Learning System for Monitoring Digital Biomarkers of Alzheimer's Disease [9.348164579913181]
  Alzheimer's Disease (AD) and related dementia are a growing global health challenge due to the aging population. We present ADMarker, the first end-to-end system that integrates multi-modal sensors and new federated learning algorithms for detecting multidimensional AD digital biomarkers in natural living environments.
  arXiv  Detail & Related papers  (2023-10-23T19:07:33Z)
• Deep Learning Predicts Biomarker Status and Discovers Related Histomorphology Characteristics for Low-Grade Glioma [21.281553456323998]
  Biomarker detection is an indispensable part in the diagnosis and treatment of low-grade glioma (LGG) We propose an interpretable deep learning pipeline to predict the status of five biomarkers in LGG using only hematoxylin and eosin-stained whole slide images and slide-level biomarker status labels. Our pipeline not only provides a novel approach for biomarker prediction, enhancing the applicability of molecular treatments for LGG patients but also facilitates the discovery of new mechanisms in molecular functionality and LGG progression.
  arXiv  Detail & Related papers  (2023-10-11T13:05:33Z)
• A marker-less human motion analysis system for motion-based biomarker discovery in knee disorders [60.99112047564336]
  The NHS has been having increased difficulty seeing all low-risk patients, this includes but not limited to suspected osteoarthritis (OA) patients. We propose a novel method of automated biomarker identification for diagnosis of knee disorders and the monitoring of treatment progression.
  arXiv  Detail & Related papers  (2023-04-26T16:47:42Z)
• Lymphocyte Classification in Hyperspectral Images of Ovarian Cancer Tissue Biopsy Samples [94.37521840642141]
  We present a machine learning pipeline to segment white blood cell pixels in hyperspectral images of biopsy cores. These cells are clinically important for diagnosis, but some prior work has struggled to incorporate them due to difficulty obtaining precise pixel labels.
  arXiv  Detail & Related papers  (2022-03-23T00:58:27Z)
• Multi-class versus One-class classifier in spontaneous speech analysis oriented to Alzheimer Disease diagnosis [58.720142291102135]
  The aim of our project is to contribute to earlier diagnosis of AD and better estimates of its severity by using automatic analysis performed through new biomarkers extracted from speech signal. The use of information about outlier and Fractal Dimension features improves the system performance.
  arXiv  Detail & Related papers  (2022-03-21T09:57:20Z)
• Adversarial Factor Models for the Generation of Improved Autism Diagnostic Biomarkers [19.48133927082379]
  We present applications of adversarial linear factor models in the creation of improved biomarkers for autism spectrum disorder (ASD) diagnosis. First, we demonstrate that an adversarial linear factor model can be used to remove confounding information from our biomarkers, ensuring that they contain only pertinent information on ASD. Second, we show this same model can be used to learn a disentangled representation of multimodal biomarkers that results in an increase in predictive performance.
  arXiv  Detail & Related papers  (2021-09-24T21:56:30Z)
• G-MIND: An End-to-End Multimodal Imaging-Genetics Framework for Biomarker Identification and Disease Classification [49.53651166356737]
  We propose a novel deep neural network architecture to integrate imaging and genetics data, as guided by diagnosis, that provides interpretable biomarkers. We have evaluated our model on a population study of schizophrenia that includes two functional MRI (fMRI) paradigms and Single Nucleotide Polymorphism (SNP) data.
  arXiv  Detail & Related papers  (2021-01-27T19:28:04Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.